Regeneron Pharmaceuticals Shares Outstanding 2006-2019 | REGN

Regeneron Pharmaceuticals shares outstanding history from 2006 to 2019. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
  • Regeneron Pharmaceuticals shares outstanding for the quarter ending December 31, 2019 were 0.115B, a 0.17% decline year-over-year.
  • Regeneron Pharmaceuticals 2019 shares outstanding were 0.115B, a 0.17% decline from 2018.
  • Regeneron Pharmaceuticals 2018 shares outstanding were 0.115B, a 0.95% decline from 2017.
  • Regeneron Pharmaceuticals 2017 shares outstanding were 0.116B, a 0.34% decline from 2016.
Regeneron Pharmaceuticals Annual Shares Outstanding
(Millions of Shares)
2019 115
2018 115
2017 116
2016 116
2015 115
2014 113
2013 111
2012 115
2011 91
2010 83
2009 80
2008 79
2007 66
2006 58
2005 56
Regeneron Pharmaceuticals Quarterly Shares Outstanding
(Millions of Shares)
Q4 2019 115
Q3 2019 114
Q2 2019 115
Q1 2019 116
Q4 2018 115
Q3 2018 115
Q2 2018 115
Q1 2018 115
Q4 2017 116
Q3 2017 117
Q2 2017 116
Q1 2017 115
Q4 2016 116
Q3 2016 116
Q2 2016 116
Q1 2016 114
Q4 2015 115
Q3 2015 116
Q2 2015 115
Q1 2015 115
Q4 2014 113
Q3 2014 117
Q2 2014 113
Q1 2014 112
Q4 2013 111
Q3 2013 117
Q2 2013 111
Q1 2013 109
Q4 2012 115
Q3 2012 116
Q2 2012 110
Q1 2012 108
Q4 2011 91
Q3 2011 91
Q2 2011 90
Q1 2011 89
Q4 2010 83
Q3 2010 82
Q2 2010 81
Q1 2010 81
Q4 2009 80
Q3 2009 80
Q2 2009 80
Q1 2009 79
Q4 2008 79
Q3 2008 79
Q2 2008 79
Q1 2008 78
Q4 2007 66
Q3 2007 66
Q2 2007 66
Q1 2007 66
Q4 2006 58
Q3 2006 57
Q2 2006 57
Q1 2006 57
Q4 2005 56
Q3 2005 56
Q2 2005 56
Q1 2005 56
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $50.379B $7.863B
Regeneron Pharmaceuticals Inc. is a biopharmaceutical company that discovers, develops, and intends to commercialize therapeutic medicines for the treatment of serious medical conditions. Regeneron has therapeutic candidates for the potential treatment of obesity, rheumatoid arthritis, cancer, and asthma and has preclinical programs in other diseases and disorders.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $126.537B 14.47
Gilead Sciences (GILD) United States $94.394B 12.17
CSL (CSLLY) Australia $92.258B 0.00
Vertex Pharmaceuticals (VRTX) United States $60.161B 54.60
Biogen (BIIB) United States $56.997B 9.73
Illumina (ILMN) United States $40.381B 41.75
Alexion Pharmaceuticals (ALXN) United States $20.984B 9.76
Seattle Genetics (SGEN) United States $19.312B 0.00
SINO PHARMACEUT (SBMFF) Hong Kong, SAR China $18.001B 0.00
Incyte (INCY) United States $16.902B 36.26
BioMarin Pharmaceutical (BMRN) United States $16.385B 701.69
Galapagos (GLPG) Belgium $15.127B 33.04
Genmab (GNMSF) Denmark $14.806B 47.62
Alnylam Pharmaceuticals (ALNY) United States $13.291B 0.00
Exact Sciences (EXAS) United States $11.950B 0.00
Bio-Rad Laboratories (BIO.B) United States $11.059B 51.67
Moderna (MRNA) United States $9.813B 0.00
BeiGene (BGNE) Cayman Islands $9.652B 0.00
Sarepta Therapeutics (SRPT) United States $8.470B 0.00
QIAGEN (QGEN) Netherlands $7.913B 24.37
Guardant Health (GH) United States $7.653B 0.00
BioNTech SE (BNTX) Germany $7.636B 0.00
Bio-Techne Corp (TECH) United States $7.587B 51.92
Horizon Therapeutics Public (HZNP) Ireland $6.580B 17.65
ACADIA Pharmaceuticals (ACAD) United States $6.195B 0.00
Ascendis Pharma (ASND) Denmark $6.195B 0.00
Reata Pharmaceuticals (RETA) United States $6.012B 0.00
Amarin (AMRN) Ireland $5.812B 0.00
ARGENX SE-ADR (ARGX) Netherlands $5.736B 0.00
Exelixis (EXEL) United States $5.708B 18.32
Acceleron Pharma (XLRN) United States $4.637B 0.00
China Biologic Products (CBPO) China $4.555B 25.66
Repligen (RGEN) United States $4.433B 81.11
Bluebird Bio (BLUE) United States $4.043B 0.00
Global Blood Therapeutics (GBT) United States $3.928B 0.00
Adaptive Biotechnologies (ADPT) United States $3.687B 0.00
MorphoSys AG (MOR) Germany $3.577B 0.00
Mirati Therapeutics (MRTX) United States $3.497B 0.00
Zai Lab (ZLAB) China $3.360B 0.00
Ultragenyx Pharmaceutical (RARE) United States $3.225B 0.00
Alkermes (ALKS) Ireland $3.197B 253.25
Immunomedics (IMMU) United States $3.164B 0.00
NeoGenomics (NEO) United States $3.131B 166.61
Blueprint Medicines (BPMC) United States $3.110B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $3.096B 52.45
Genmab (GMAB) Denmark $3.090B 12.12
Momenta Pharmaceuticals (MNTA) United States $3.042B 0.00
Emergent Biosolutions (EBS) United States $3.038B 21.09
MyoKardia (MYOK) United States $2.981B 0.00
Intercept Pharmaceuticals (ICPT) United States $2.948B 0.00
Halozyme Therapeutics (HALO) United States $2.926B 0.00
Amicus Therapeutics (FOLD) United States $2.510B 0.00
Fate Therapeutics (FATE) United States $2.410B 0.00
Insmed (INSM) United States $2.363B 0.00
Arena Pharmaceuticals (ARNA) United States $2.345B 6.12
UniQure (QURE) Netherlands $2.336B 0.00
Principia Biopharma (PRNB) United States $2.217B 0.00
RA PHARMCTL INC (RARX) United States $2.200B 0.00
Denali Therapeutics (DNLI) United States $2.077B 0.00
Epizyme (EPZM) United States $1.971B 0.00
Alector (ALEC) United States $1.889B 0.00
Ligand Pharmaceuticals (LGND) United States $1.802B 52.63
Eidos Therapeutics (EIDX) United States $1.801B 0.00
REGENXBIO (RGNX) United States $1.748B 0.00
Akcea Therapeutics (AKCA) United States $1.683B 38.96
Arvinas (ARVN) United States $1.638B 0.00
Zymeworks (ZYME) Canada $1.593B 0.00
Coherus BioSciences (CHRS) United States $1.429B 0.00
Zealand Pharma (ZLDPF) Denmark $1.412B 0.00
Dicerna Pharmaceuticals (DRNA) United States $1.391B 0.00
Zealand Pharma (ZEAL) Denmark $1.343B 0.00
Myriad Genetics (MYGN) United States $1.337B 23.59
Nabriva Therapeutics AG (NBRV) Ireland $1.295B 0.00
Intra-Cellular Therapies (ITCI) United States $1.233B 0.00
Editas Medicine (EDIT) United States $1.150B 0.00
Revance Therapeutics (RVNC) United States $1.125B 0.00
Orchard Therapeutics (ORTX) United Kingdom $1.105B 0.00
Twist Bioscience (TWST) United States $1.089B 0.00
BAVARIAN NORDIC (BVNRY) Denmark $1.050B 0.00
Athenex (ATNX) United States $1.000B 0.00
PHARMA MAR SA (PHMMF) Spain $0.914B 0.00
DBV Technologies S.A (DBVT) France $0.906B 0.00
Mesoblast (MESO) Australia $0.885B 0.00
Pharming Group (PHGUF) Netherlands $0.857B 0.00
Adverum Biotechnologies (ADVM) United States $0.834B 0.00
Cytokineticsorporated (CYTK) United States $0.831B 0.00
Sangamo Therapeutics (SGMO) United States $0.799B 0.00
Heska (HSKA) United States $0.780B 0.00
Codexis (CDXS) United States $0.760B 0.00
Intrexon (PGEN) United States $0.721B 0.00
ANI Pharmaceuticals (ANIP) United States $0.717B 12.23
Cellectis S.A (CLLS) France $0.711B 0.00
Arcus Biosciences (RCUS) United States $0.700B 0.00
Vericel (VCEL) United States $0.676B 100.27
Retrophin (RTRX) United States $0.659B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.640B 0.00
Cara Therapeutics (CARA) United States $0.635B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.604B 5.34
Anika Therapeutics (ANIK) United States $0.603B 20.61
Intellia Therapeutics (NTLA) United States $0.601B 0.00
GENFIT S.A (GNFT) France $0.595B 0.00
UROGEN PHARMA (URGN) United States $0.594B 0.00
ZIOPHARM Oncology Inc (ZIOP) United States $0.587B 0.00
Kadmon Holdings (KDMN) United States $0.575B 0.00
OXFORD BIOMEDCL (OXBDF) United Kingdom $0.540B 0.00
Bellus Health (BLU) Canada $0.509B 0.00
AC Immune SA (ACIU) Switzerland $0.494B 11.42
Aquinox Pharmaceuticals (NLTX) United States $0.486B 0.00
NantKwest (NK) United States $0.485B 0.00
Prothena (PRTA) Ireland $0.479B 0.00
Sinovac Biotech (SVA) China $0.460B 0.00
Mersana Therapeutics (MRSN) United States $0.444B 0.00
BioDelivery Sciences (BDSI) United States $0.441B 0.00
Cue Biopharma (CUE) United States $0.435B 0.00
Compugen (CGEN) Israel $0.433B 0.00
AnaptysBio (ANAB) United States $0.429B 0.00
Puma Biotechnology (PBYI) United States $0.413B 0.00
Clovis Oncology (CLVS) United States $0.410B 0.00
Precision BioSciences (DTIL) United States $0.409B 0.00
Agenus (AGEN) United States $0.405B 0.00
Inovio Pharmaceuticals (INO) United States $0.404B 0.00
Pfenex (PFNX) United States $0.399B 0.00
Merus (MRUS) Netherlands $0.397B 0.00
Cel-Sci (CVM) United States $0.395B 0.00
Kindred Biosciences (KIN) United States $0.394B 0.00
PDL BioPharma (PDLI) United States $0.387B 9.69
Sorrento Therapeutics (SRNE) United States $0.376B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.373B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.367B 0.00
Avid Bioservices (CDMO) United States $0.366B 0.00
Dynavax Technologies (DVAX) United States $0.361B 0.00
Xenon Pharmaceuticals (XENE) Canada $0.356B 0.00
CytomX Therapeutics (CTMX) United States $0.330B 0.00
Cellular Biomedicine (CBMG) United States $0.324B 0.00
Gritstone Oncology (GRTS) United States $0.318B 0.00
Stemline Therapeutics (STML) United States $0.307B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.303B 2.10
MannKind (MNKD) United States $0.297B 0.00
Novavax (NVAX) United States $0.296B 0.00
Albireo Pharma (ALBO) United States $0.296B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.294B 0.00
WAVE Life Sciences (WVE) Singapore $0.290B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.282B 0.00
OSMOTICA PHARM (OSMT) United States $0.281B 0.00
Aduro Biotech (ADRO) United States $0.275B 0.00
Kamada (KMDA) Israel $0.273B 11.37
Syros Pharmaceuticals (SYRS) United States $0.273B 0.00
Starpharma Holdings (SPHRY) Australia $0.272B 0.00
AMAG Pharmaceuticals (AMAG) United States $0.271B 0.00
Seres Therapeutics (MCRB) United States $0.250B 0.00
Biofrontera AG (BFRA) Germany $0.246B 0.00
Sutro Biopharma (STRO) United States $0.232B 0.00
IVERIC Bio (ISEE) United States $0.232B 0.00
Geron (GERN) United States $0.228B 0.00
VBI Vaccines (VBIV) United States $0.226B 0.00
Protagonist Therapeutics (PTGX) United States $0.226B 0.00
Kala Pharmaceuticals (KALA) United States $0.222B 0.00
POXEL SA FRANCE (PXXLF) France $0.220B 0.00
Prometic Life Sciences (LMNL) Canada $0.216B 0.00
Aeglea BioTherapeutics (AGLE) United States $0.214B 0.00
XOMA (XOMA) United States $0.212B 0.00
Alcobra (ARCT) United States $0.212B 0.00
Nymox Pharmaceutical (NYMX) Canada $0.209B 0.00
ChromaDex (CDXC) United States $0.206B 0.00
TELA Bio (TELA) United States $0.199B 0.00
Athersys (ATHX) United States $0.191B 0.00
ADMA Biologics Inc (ADMA) United States $0.189B 0.00
Abeona Therapeutics (ABEO) United States $0.189B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.187B 0.00
Theratechnologies (THTX) Canada $0.186B 0.00
Affimed (AFMD) Germany $0.185B 0.00
Spero Therapeutics (SPRO) United States $0.183B 0.00
VTv Therapeutics (VTVT) United States $0.180B 0.00
Cerecor (CERC) United States $0.177B 0.00
Five Prime Therapeutics (FPRX) United States $0.176B 0.00
Arbutus Biopharma (ABUS) Canada $0.174B 0.00
VolitionRX (VNRX) Singapore $0.173B 0.00
Lineage Cell Therapeutics (LCTX) United States $0.169B 8.69
Exicure (XCUR) United States $0.169B 0.00
Windtree Therapeutics (WINT) United States $0.164B 0.00
Fortress Biotech (FBIO) United States $0.163B 0.00
Selecta Biosciences (SELB) United States $0.159B 0.00
Verastem (VSTM) United States $0.149B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.146B 0.00
Paratek Pharmaceuticals (PRTK) United States $0.144B 0.00
CorMedix Inc (CRMD) United States $0.144B 0.00
Dyadic (DYAI) United States $0.143B 0.00
Strongbridge Biopharma (SBBP) United States $0.143B 0.00
Antibe Therapeutics (ATBPF) Canada $0.139B 0.00
Celyad SA (CYAD) Belgium $0.137B 0.00
Arsanis (XFOR) United States $0.137B 0.00
Aptinyx (APTX) United States $0.137B 0.00
Liquidia Technologies (LQDA) United States $0.136B 0.00
Newron Pharmaceuticals SpA (NWPHF) Italy $0.134B 0.00
ARAVIVE, INC (ARAV) United States $0.132B 0.00
Northwest Biotherapeutics (NWBO) United States $0.130B 0.00
PHASEBIO PHARMA (PHAS) United States $0.125B 0.00
Palatin Technologies (PTN) United States $0.118B 3.22
Happiness Biotech Group (HAPP) China $0.117B 0.00
OvaScience (MLND) United States $0.117B 0.00
Clearside Biomedical (CLSD) United States $0.111B 0.00
Vaccinex (VCNX) United States $0.110B 0.00
Enzo Biochem (ENZ) United States $0.106B 0.00
Prima BioMed (IMMP) Australia $0.106B 0.00
Sunesis Pharmaceuticals (SNSS) United States $0.102B 0.00
AIT Therapeutics (XAIR) United States $0.102B 0.00
Applied Genetic Technologies (AGTC) United States $0.090B 0.00
Adocia (ADOCY) France $0.086B 0.00
Proteostasis Therapeutics (PTI) United States $0.085B 0.00
Checkpoint Therapeutics (CKPT) United States $0.084B 0.00
SESEN BIO, INC (SESN) United States $0.083B 0.00
AVEO Pharmaceuticals (AVEO) United States $0.080B 0.00
Catalyst Biosciences (CBIO) United States $0.074B 0.00
Synlogic (SYBX) United States $0.074B 0.00
Emmaus Life Sciences (EMMA) United States $0.073B 0.00
Menlo Therapeutics (MNLO) United States $0.073B 0.00
Pluristem Therapeutics (PSTI) Israel $0.073B 0.00
Orgenesis (ORGS) United States $0.070B 4.52
ANIXA BIOSCIENCES INC (ANIX) United States $0.068B 0.00
Aridis Pharmaceuticals (ARDS) United States $0.066B 0.00
Trevena (TRVN) United States $0.065B 0.00
Acorda Therapeutics (ACOR) United States $0.063B 0.00
DiaMedica Therapeutics (DMAC) United States $0.061B 0.00
Catabasis Pharmaceuticals (CATB) United States $0.060B 0.00
Soligenix (SNGX) United States $0.058B 0.00
China Health Industries Holdings (CHHE) China $0.054B 16.49
Advaxis (ADXS) United States $0.054B 0.00
Protalix BioTherapeutics (PLX) Israel $0.053B 0.00
NewLink Genetics (NLNK) United States $0.052B 0.00
Vascular Biogenics (VBLT) Israel $0.048B 0.00
Idera Pharmaceuticals (IDRA) United States $0.045B 0.00
CollPlant Holdings (CLGN) Israel $0.045B 0.00
Celldex Therapeutics (CLDX) United States $0.042B 0.00
TOCAGEN INC (TOCA) United States $0.041B 0.00
AquaBounty Technologies (AQB) United States $0.040B 0.00
Cleveland BioLabs (CBLI) United States $0.038B 0.00
Curis (CRIS) United States $0.038B 0.00
AmpliPhi Biosciences (ARMP) United States $0.038B 0.00
Organovo Holdings (ONVO) United States $0.037B 0.00
Evogene (EVGN) Israel $0.036B 0.00
Entera Bio (ENTX) Israel $0.033B 0.00
Alimera Sciences (ALIM) United States $0.030B 0.00
VistaGen Therapeutics (VTGN) United States $0.029B 0.00
Pulmatrix (PULM) United States $0.028B 0.00
Bionano Genomics (BNGO) United States $0.028B 0.00
Celsion (CLSN) United States $0.028B 0.00
Stellar Biotechnologies (EDSA) Canada $0.027B 0.00
Aerpio Pharmaceuticals (ARPO) United States $0.026B 0.00
Novogen (KZIA) Australia $0.025B 0.00
IBio (IBIO) United States $0.025B 0.00
BioCardia (BCDA) United States $0.025B 0.00
Signal Genetics (MGEN) United States $0.024B 0.00
Oncobiologics (OTLK) United States $0.023B 0.00
VIVUS (VVUS) United States $0.022B 0.00
Unum Therapeutics (UMRX) United States $0.020B 0.00
Aptevo Therapeutics (APVO) United States $0.020B 0.00
AEterna Zentaris (AEZS) United States $0.018B 0.00
Aytu Bioscience (AYTU) United States $0.017B 0.00
Genetic Technologies (GENE) Australia $0.014B 0.00
Titan Pharmaceuticals (TTNP) United States $0.014B 0.00
PLANET GREEN HOLDINGS CORP (PLAG) China $0.013B 0.00
IMMURON (IMRN) Australia $0.013B 0.00
MYOS RENS Technology (MYOS) United States $0.011B 0.00
Cesca Therapeutics (THMO) United States $0.011B 0.00
TrovaGene (TROV) United States $0.011B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.011B 0.00
Prana Biotechnology (ATHE) Australia $0.010B 0.00
TRACON Pharmaceuticals (TCON) United States $0.010B 0.00
Benitec Biopharma (BNTC) Australia $0.007B 0.00
BioPharmX (BPMX) United States $0.007B 0.00
Neuralstem (SNCA) United States $0.003B 0.00